GAMMA Investing’s Kailera Therapeutics KLRA Stock Holding History

GAMMA Investing’s Portfolio KLRA Stock Details KLRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$388	Buy	+34	New	+$575	﹤0.01%	4231

Other funds holding KLRA

MCP

Mirador Capital Partners Pleasanton, California $859M AUM 41.74% 1-Year Est. Return

VCM

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

GAMMA Investing's KLRA Position: Q3 2026 in Review

GAMMA Investing opened a new position in Kailera Therapeutics (KLRA) in Q3 2026: 34 shares worth $388. The stake represents ﹤0.01% of the portfolio and ranks #4231 among its holdings.

4 funds tracked by Wall St. Rank hold KLRA as of Q3 2026.

GAMMA Investing held 34 shares of Kailera Therapeutics worth $388 as of Q3 2026.
Kailera Therapeutics was a new GAMMA Investing position in Q3 2026.
Kailera Therapeutics made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #4231 holding.
4 funds tracked by Wall St. Rank held Kailera Therapeutics as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.